Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial

DOI: 10.1186/s40880-018-0300-5

Keywords: Obinutuzumab, B-cell lymphoma, Chronic lymphocytic leukemia, Chinese patients

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s40880-018-0300-5) contains supplementary material, which is available to authorized users

Full-Text